JPWO2020041498A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020041498A5
JPWO2020041498A5 JP2021509223A JP2021509223A JPWO2020041498A5 JP WO2020041498 A5 JPWO2020041498 A5 JP WO2020041498A5 JP 2021509223 A JP2021509223 A JP 2021509223A JP 2021509223 A JP2021509223 A JP 2021509223A JP WO2020041498 A5 JPWO2020041498 A5 JP WO2020041498A5
Authority
JP
Japan
Prior art keywords
sequence
aav
gpr108
seq
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021509223A
Other languages
English (en)
Japanese (ja)
Other versions
JP7451497B2 (ja
JP2021533795A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/047546 external-priority patent/WO2020041498A1/en
Publication of JP2021533795A publication Critical patent/JP2021533795A/ja
Publication of JPWO2020041498A5 publication Critical patent/JPWO2020041498A5/ja
Application granted granted Critical
Publication of JP7451497B2 publication Critical patent/JP7451497B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021509223A 2018-08-21 2019-08-21 アデノ随伴ウイルスの形質導入効率を調節するための組成物および方法 Active JP7451497B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862720859P 2018-08-21 2018-08-21
US62/720,859 2018-08-21
PCT/US2019/047546 WO2020041498A1 (en) 2018-08-21 2019-08-21 Compositions and methods for modulating transduction efficiency of adeno-associated viruses

Publications (3)

Publication Number Publication Date
JP2021533795A JP2021533795A (ja) 2021-12-09
JPWO2020041498A5 true JPWO2020041498A5 (enExample) 2022-07-25
JP7451497B2 JP7451497B2 (ja) 2024-03-18

Family

ID=69591093

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021509223A Active JP7451497B2 (ja) 2018-08-21 2019-08-21 アデノ随伴ウイルスの形質導入効率を調節するための組成物および方法

Country Status (5)

Country Link
US (1) US12195745B2 (enExample)
EP (1) EP3841109A4 (enExample)
JP (1) JP7451497B2 (enExample)
AU (1) AU2019325332B2 (enExample)
WO (1) WO2020041498A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112020022858A2 (pt) 2018-05-11 2021-02-23 Massachusetts Eye And Ear Infirmary tropismo específico hepático de vírus adeno-associado
EP4087391A1 (en) 2020-04-09 2022-11-16 University of Sheffield Gene therapy treatment
WO2022103826A1 (en) * 2020-11-10 2022-05-19 The Children's Hospital Of Philadelphia Compositons and methods for in vivo gene transfer
GB202215198D0 (en) 2022-10-14 2022-11-30 Univ Sheffield Gene therapy treatment
WO2025114699A1 (en) 2023-11-30 2025-06-05 Cytomos Limited Cell selection
WO2025188755A1 (en) 2024-03-04 2025-09-12 Kate Therapeutics, Inc. Adeno-associated virus compositions for the treatment of duchenne muscular dystrophy
WO2025226841A1 (en) 2024-04-24 2025-10-30 Kate Therapeutics, Inc. Gene therapy approach for treating disorders associated with tnnt2
WO2025226842A1 (en) 2024-04-24 2025-10-30 Kate Therapeutics, Inc. Expression control by drg-expressed mirnas

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6855314B1 (en) * 2000-03-22 2005-02-15 The United States Of America As Represented By The Department Of Health And Human Services AAV5 vector for transducing brain cells and lung cells
EP1572893B1 (en) 2001-11-09 2009-01-07 THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by THE SECRETARY of the DEPARTMENT OF HEALTH AND HUMAN SERVICES Production of adeno-associated virus in insect cells
AU2003295312B2 (en) * 2002-05-01 2008-08-14 University Of Florida Research Foundation, Inc. Improved rAAV expression systems for genetic modification of specific capsid proteins
US20060166363A1 (en) * 2004-01-27 2006-07-27 Sergei Zolotukhin Modified baculovirus expression system for production of pseudotyped rAAV vector
EP3409296A1 (en) * 2005-04-07 2018-12-05 The Trustees of the University of Pennsylvania Method of increasing the function of an aav vector
DK2954051T3 (da) * 2013-02-08 2019-07-08 Univ Pennsylvania Modificeret kapsid til genoverførsel til behandling af nethinden
RU2738421C2 (ru) * 2014-10-21 2020-12-14 Юниверсити Оф Массачусетс Варианты рекомбинантных aav и их применения
US10081659B2 (en) * 2015-04-06 2018-09-25 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Adeno-associated vectors for enhanced transduction and reduced immunogenicity
US10633662B2 (en) 2015-11-10 2020-04-28 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for modulating AAV infection
EP3448874A4 (en) * 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
MX2018013463A (es) * 2016-05-13 2019-07-04 4D Molecular Therapeutics Inc Capsides variantes de virus adenoasociados y metodos de uso de las mismas.
EP3491008A2 (en) 2016-07-26 2019-06-05 BioMarin Pharmaceutical Inc. Novel adeno-associated virus capsid proteins
US11698377B2 (en) * 2016-08-15 2023-07-11 Genzyme Corporation Methods for detecting AAV
WO2018119330A2 (en) * 2016-12-22 2018-06-28 Oregon Health & Science University Adeno associated viral vectors
US20210292373A1 (en) 2018-07-10 2021-09-23 University Of Florida Research Foundation, Incorporated Aav vp1u chimeras
TW202532428A (zh) * 2019-04-26 2025-08-16 美商愛德維仁生物科技公司 用於玻璃體內遞送之變異體aav蛋白殼

Similar Documents

Publication Publication Date Title
JP2022190081A5 (enExample)
US11015189B2 (en) AAV capsid proteins for nucleic acid transfer
CN109715650B (zh) 新颖腺相关病毒衣壳蛋白
IL317938A (en) Recombinant viral vectors with altered tropism and their uses for the targeted introduction of genetic material into human cells
JP2020019772A5 (enExample)
KR20250025387A (ko) Aav 캡시드 변이체 및 이의 용도
AU2018323049B2 (en) Adeno-associated virus (AAV) with modified phospholipase domain
JP2020519284A5 (enExample)
JP2025004107A (ja) ガラクトース血症の処置のための遺伝子治療
TW202246516A (zh) 病毒蛋白之控制表現
JP2020519294A5 (enExample)
JPWO2020041498A5 (enExample)
JP2025517628A (ja) 新規の組換えaav vp2融合ポリペプチド
JPWO2021053222A5 (enExample)
CN120548368A (zh) 用于正确包装重复元件的腺相关病毒载体
JPWO2019173538A5 (enExample)
JPWO2020168222A5 (enExample)
JPWO2020186150A5 (enExample)
JPWO2020159970A5 (enExample)
CA3138274A1 (en) Intrathecal and intravenous combination gene therapy for the treatment of infantile batten disease
RU2024111148A (ru) Вирусные частицы, перенацеленные на скелетные мышцы
JPWO2022235933A5 (enExample)
HK40048783A (en) New avv capsid proteins for nucleic acid transfer
JPWO2021195218A5 (enExample)
RU2021133286A (ru) Модифицированные вирусные частицы и пути их применения